Full text is available at the source.
Abstract
Metabolic bariatric surgery (MBS) and incretin-based therapy (IBT) are effective treatments for obesity and type 2 diabetes.
- The effectiveness of MBS and IBT in treating obesity and type 2 diabetes is recognized.
- There is a lack of comprehensive data on the comparative effectiveness of these two treatment options in current clinical practice.
- Further investigation is needed to clarify how MBS and IBT compare in real-world settings.
Simplified